Connect your AI

Janus Living JAN Cumulative Cost Basis

Cumulative Cost Basis at other companies

Fidelity National Information ServicesFIS

——

Nasdaq, Inc.NDAQ

——

Indivior Pharmaceuticals, Inc. INDV

——

Krystal Biotech, Inc.KRYS

——

BridgeBio PharmaBBIO

——

IncyteINCY

——

Other financials

Income statement

Revenue$4.7M-2.8%

Gross profit$3.6M+85.6%

Operating income-$2.7M-41.0%

Net income-$271.5M-11,250%

EPS (diluted)-$2.14-1,327%

Balance sheet

Cash & equivalents$10.5M-2.7%

Total debt$107.0K-99.4%

Total equity$889.7M+3,976%

Total assets$959.7M+1,130%

Cash flow

Operating cash flow-$12.3M-764%

CapEx$2.8K—

Free cash flow-$1.8M—

Valuation

Market cap$5.56B+43,568%

Enterprise value$5.55B+26,232%

P/S231.5×+231×

Profitability

Gross margin46.5%+1.2pp

Operating margin-99.7%-717pp

Net margin-2,552.7%-2,601pp

FCF margin-29.7%—

Returns & leverage

Return on equity-134.6%-791pp

Debt / equity0×-0.5×

Current ratio0.8×0.0×

Where this comes from

Reported directly by Janus Living in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Janus Living ’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janus Living 's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Janus Living 's cumulative cost basis?: Janus Living (JAN) reported cumulative cost basis of $65K in Q1 2026.